Group
The 18th annual IBEC Symposium focused on ‘Bioengineering for Precision Medicine’, which is one of IBEC’s key areas of application. The event was attended by nearly 300 people, including local and international researchers. The multidisciplinary environment provided experts from other centres and the IBEC community with the opportunity to present their projects and exchange knowledge.
A study led by the Institute for Bioengineering of Catalonia (IBEC) has revealed that protons and reactive oxygen species mediate long-distance charge transport in the mitochondrial respiratory chain — a fundamental process in cellular respiration in organisms. Understanding these mechanisms is crucial, given that mitochondria are the powerhouses of all cells and alterations to them are associated with numerous diseases.
Universitats i centres de recerca han unit esforços sota el paraigua de la Fundació Catalana per a la Recerca i la Innovació (FCRI) per aconseguir que la ciència al Saló de l’Ensenyament literalment es pugui viure i tocar.
A study led by the Institute for Bioengineering of Catalonia (IBEC) and the CIBER’s Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) describes a method that mimics the physiological response to smell. The system makes it possible to discriminate between odours with very similar characteristics based on the binding interaction with the receptor, which causes a change in the capacitive response of the receptor. The application of this methodology opens the door to the development of highly selective olfactory biosensors.
The Institute for Bioengineering of Catalonia and the Sant Joan de Déu Barcelona Children’s Hospital have held a joint conference to strengthen collaboration in bioengineering and translational medicine. The event, held this morning at the IBEC, highlighted innovative projects, presented a joint PhD programme and encouraged the exchange of ideas between researchers from both institutions.
A team of researchers led by IBEC and ICFO has developed and validated a novel photoelectrochemical electron spectroscopy technique to probe charge separation dynamics, a crucial step for photosynthesis, in photosynthetic complexes.
A team of researchers led by the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. These compounds, which show analgesic effects when activated by light, can inhibit nerve signals locally and on demand. Photopharmacological treatments offer precise action at the site of application, thus reducing systemic side effects.
The IBEC senior researchers were two of the winners of the fourth edition of the call for applications. Through this initiative, BIST recognises and supports scientist mothers working to reach a leading position and advance the research in their fields.
The IBEC is set to lead the coordination of the PHOTOTHERAPORT project, which will be developed with funding from the European Innovation Council’s Pathfinder Open programme. The project focuses on the development of luminescent implants and light-activated drugs for innovative neuromodulation therapies. PHOTOTHERAPORT will comprise an international consortium of 8 institutions and will receive €3 million over 3 years for the preclinical study of these implants.
